Aritojung 20 mg (Atorvastatin Calcium Hydrate)

Adult dose

The recommended starting dose for adults is 10 mg of atorvastatin once daily, and for patients requiring greater reductions in LDL cholesterol levels, it can be initiated at 20 mg or 40 mg once daily. The drug is administered in a dosage range of 10 to 80 mg once daily, with the starting and maintenance doses individualized based on treatment goals and patient characteristics. After initiating treatment and dosage adjustments, lipid levels should be analyzed within 2 to 4 weeks to adjust doses accordingly.

Child dose

The recommended starting dose for pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17) is 10 mg once daily, with a recommended maximum dose of 20 mg per day. Dosage adjustments should be made according to the recommended treatment goals.

This medication may cause abnormal symptoms in muscles, so if there is severe or persistent muscle pain or weakness, consult a doctor immediately. Patients at higher risk of muscle damage may need to temporarily suspend or discontinue use of this medication. This drug should not be administered to patients with certain liver diseases or those with severely impaired liver function. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication. Children under 10 years of age should not use this drug, and the safety and efficacy in adolescents under 18 years have not been adequately studied. Patients with a history of alcohol addiction or liver diseases should use this medication with caution. This drug may interact with other medications, so it is essential to inform the doctor or pharmacist of any medications being taken. Caution is particularly needed when combined with certain antibiotics, antifungals, protease inhibitors, and some cardiovascular drugs. Regular liver function tests are required while taking this medication, and if symptoms of hepatitis (nausea, vomiting, fatigue, etc.) occur, inform the medical personnel immediately. Appropriate contraception should be used while taking this drug, and it should be discontinued immediately if pregnancy is confirmed. There is no specific antidote for overdose, so treatment should be based on symptoms, and liver function and muscle enzyme levels should be monitored. This medication should be stored out of the reach of children and kept in its original container. Elderly patients are at higher risk of muscle-related problems, and caution is needed during their use, while patients with impaired renal function should also be monitored for muscle issues. If muscle-related symptoms or severe side effects are suspected, notify medical personnel immediately and undergo necessary tests.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, paleness, severe allergic reactions, high fever with severe rash, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities with cough + fever, breathing problems, yellowing of the skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden and

Mild side effects

• Weakness
• fatigue
• chest pain
• peripheral edema
• tiredness
• fever
• nasopharyngitis
• hyperglycemia
• hypoglycemia
• weight gain

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is best to maintain storage temperatures between 1 and 30 degrees Celsius.

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle